×
About 27,936 results

ALLMedicine™ Cannabis Center

Research & Reviews  12,921 results

Trends in cannabis use and attitudes towards legalization and use among Australians fro...
https://doi.org/10.1111/add.15271
Addiction (Abingdon, England); Kaur N, Keyes KM et. al.

Sep 19th, 2020 - Changes in cannabis legalization and availability in Australia necessitate monitoring use and attitudes. We estimated age-period-cohort effects of past-year cannabis use and attitudes towards criminalization and legalization. Analysis of six waves...

Cannabis use and sleep: Expectations, outcomes, and the role of age.
https://doi.org/10.1016/j.addbeh.2020.106642
Addictive Behaviors; Winiger EA, Hitchcock LN et. al.

Sep 19th, 2020 - Determine relationship between cannabis use with 1) expectations of cannabis being a sleep aid, 2) subjective sleep outcomes, and 3) the influence of age on these relationships. In 152 moderate cannabis users with a wide age range (67% female, mea...

BRANCH RETINAL ARTERY OCCLUSION WITH PARACENTRAL ACUTE MIDDLE MACULOPATHY PRESUMABLY RE...
https://doi.org/10.1097/ICB.0000000000001051
Retinal Cases & Brief Reports; Ramtohul P, Bailey Freund K et. al.

Sep 18th, 2020 - To report a case of branch retinal artery occlusion associated with paracentral acute middle maculopathy on spectral domain-optical coherence tomography (SD-OCT) presumably related to heavy cannabis consumption. Retrospective case report. SD-OCT, ...

General risks of harm with cannabinoids, cannabis, and cannabis-based medicine possibly...
https://doi.org/10.1097/j.pain.0000000000002000
Pain Mohiuddin M, Blyth FM et. al.

Sep 17th, 2020 - The growing demand for improved pain treatments together with expanding legalization of, and access to, cannabinoids, cannabis, and cannabis-based medicines has intensified the focus on risk-benefit considerations in pain management. Given limited...

The COVID-19 cannabis health study: Results from an epidemiologic assessment of adults ...
https://doi.org/10.1080/10550887.2020.1811455
Journal of Addictive Diseases; Vidot DC, Islam JY et. al.

Sep 16th, 2020 - Clinical indications for medicinal cannabis include chronic conditions; thus users (MCUs) are at an increased risk of morbidity and mortality resulting from SARS-CoV-2 infection (COVID-19). The study aimed to provide data on cannabis use and self-...

see more →

Guidelines  79 results

Medical Cannabis in Cancer Patients
https://journals.lww.com/amjclinicaloncology/Abstract/2020/09000/Medical_Cannabis_in_Cancer_Patients__A_Survey_of_a.5.aspx
American J Clin Oncol; Macari DM

Aug 31st, 2020 - Cancer patients are using medical cannabis (MC) to address symptoms; however, little data exist to guide clinicians when counseling patients. We seek to define the patterns of MC use among cancer patients, as well as efficacy and safety of MC.

Cannabinoids in cancer treatment: Therapeutic potential and legislation
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387667/
Bosnian Journal of Basic Medical Sciences; Daris B,et al

Feb 27th, 2020 - The plant Cannabis sativa L. has been used as an herbal remedy for centuries and is the most important source of phytocannabinoids. The endocannabinoid system (ECS) consists of receptors, endogenous ligands (endocannabinoids) and metabolizing enzy...

Cannabis and Coronavirus: What Cannabis Patients Want to Know
https://docsntalks.com/2020/02/18/cannabis-and-coronavirus-what-cannabis-patients-want-to-know/
Docs N Talks; Weeks M

Feb 17th, 2020 - At the time of writing, there were 69, 287 confirmed cases of the coronavirus and 1670 deaths. With the rapid escalation of the outbreak, these numbers will surely be outdated by the time of publication. With several regions heading into states of...

Use of cannabinoids in cancer patients: A Society of Gynecologic Oncology (SGO) clinical practice statement
https://www.gynecologiconcology-online.net/article/S0090-8258(19)31805-0/fulltext
Gynecology Oncology; Whitcomb B,et al

Jan 12th, 2020 - Providers should focus indications, alternatives, risks and benefits of medical cannabis use to make appropriate referrals.

Cannabis Enthusiasts' Knowledge of Medical Treatment Effectiveness and Increased Risks From Cannabis Use
https://journals.sagepub.com/doi/full/10.1177/0890117119899218?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Am J Health Promotion; Kruger DJ,et al

Jan 8th, 2020 - There were considerable discrepancies between cannabis users’ knowledge and available evidence, highlighting the need for more research and education (by physicians, caregivers, and dispensaries) on effectiveness and health risks, especially for u...

see more →

Drugs  19 results see all →

Clinicaltrials.gov  13,735 results

Trends in cannabis use and attitudes towards legalization and use among Australians fro...
https://doi.org/10.1111/add.15271
Addiction (Abingdon, England); Kaur N, Keyes KM et. al.

Sep 19th, 2020 - Changes in cannabis legalization and availability in Australia necessitate monitoring use and attitudes. We estimated age-period-cohort effects of past-year cannabis use and attitudes towards criminalization and legalization. Analysis of six waves...

Cannabis use and sleep: Expectations, outcomes, and the role of age.
https://doi.org/10.1016/j.addbeh.2020.106642
Addictive Behaviors; Winiger EA, Hitchcock LN et. al.

Sep 19th, 2020 - Determine relationship between cannabis use with 1) expectations of cannabis being a sleep aid, 2) subjective sleep outcomes, and 3) the influence of age on these relationships. In 152 moderate cannabis users with a wide age range (67% female, mea...

BRANCH RETINAL ARTERY OCCLUSION WITH PARACENTRAL ACUTE MIDDLE MACULOPATHY PRESUMABLY RE...
https://doi.org/10.1097/ICB.0000000000001051
Retinal Cases & Brief Reports; Ramtohul P, Bailey Freund K et. al.

Sep 18th, 2020 - To report a case of branch retinal artery occlusion associated with paracentral acute middle maculopathy on spectral domain-optical coherence tomography (SD-OCT) presumably related to heavy cannabis consumption. Retrospective case report. SD-OCT, ...

General risks of harm with cannabinoids, cannabis, and cannabis-based medicine possibly...
https://doi.org/10.1097/j.pain.0000000000002000
Pain Mohiuddin M, Blyth FM et. al.

Sep 17th, 2020 - The growing demand for improved pain treatments together with expanding legalization of, and access to, cannabinoids, cannabis, and cannabis-based medicines has intensified the focus on risk-benefit considerations in pain management. Given limited...

The COVID-19 cannabis health study: Results from an epidemiologic assessment of adults ...
https://doi.org/10.1080/10550887.2020.1811455
Journal of Addictive Diseases; Vidot DC, Islam JY et. al.

Sep 16th, 2020 - Clinical indications for medicinal cannabis include chronic conditions; thus users (MCUs) are at an increased risk of morbidity and mortality resulting from SARS-CoV-2 infection (COVID-19). The study aimed to provide data on cannabis use and self-...

see more →

News  1,179 results

Medical Cannabis in Cancer Patients
https://journals.lww.com/amjclinicaloncology/Abstract/2020/09000/Medical_Cannabis_in_Cancer_Patients__A_Survey_of_a.5.aspx
American J Clin Oncol; Macari DM

Aug 31st, 2020 - Cancer patients are using medical cannabis (MC) to address symptoms; however, little data exist to guide clinicians when counseling patients. We seek to define the patterns of MC use among cancer patients, as well as efficacy and safety of MC.

Apax mulls sale of Neuraxpharm to lock in pharma sector premium: sources
https://www.reuters.com/article/us-neuraxpharm-sale/apax-mulls-sale-of-neuraxpharm-to-lock-in-pharma-sector-premium-sources-idUSKBN24A256

Jul 9th, 2020 - FRANKFURT (Reuters) - Buyout group Apax is preparing the sale of German pharma group Neuraxpharm to try to lock in high valuations in the healthcare sector, fuelled by the coronavirus pandemic, sources familiar with the matter said. Apax has alrea...

Zynerba's cannabis-based drug for rare genetic disorder fails study
https://www.reuters.com/article/us-zynerba-pharms-study/zynerbas-cannabis-based-drug-for-rare-genetic-disorder-fails-study-idUSKBN2411Q2

Jun 30th, 2020 - (Reuters) - Zynerba Pharmaceuticals Inc said on Tuesday its experimental cannabis-based gel Zygel was not statistically significant in improving aberrant behavior when compared to a placebo in patients with a neurological disorder called Fragile X...

In Brazil's shadow, laid-back Uruguay curbs COVID-19
https://www.reuters.com/article/us-health-coronavirus-uruguay/in-brazils-shadow-laid-back-uruguay-curbs-covid-19-idUSKBN2340EG

May 28th, 2020 - MONTEVIDEO (Reuters) - Leonardo Silveira, a bookstore owner in Montevideo, is hopeful about the future as Uruguay begins a gradual reopening. The small country has kept rates of COVID-19 at one of the lowest levels in Latin America, even as the re...

Israel approves medical cannabis exports
https://www.reuters.com/article/us-israel-cannabis-exports/israel-approves-medical-cannabis-exports-idUSKBN22P2FW

May 13th, 2020 - FILE PHOTO: An employee tends to medical cannabis plants at Pharmocann, an Israeli medical cannabis company in northern Israel January 24, 2019. REUTERS/Amir Cohen/File Photo TEL AVIV (Reuters) - Israel gave approval on Wednesday for exports of me...

see more →

Patient Education  3 results see all →